Ilex Capital Partners’s Colgate-Palmolive CL Stock Holding History

Ilex Capital Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,087,190	Closed	-$165M	–	79
2025 Q4	$165M	Buy	+2,087,190	New	+$164M	4.65%	5
2025 Q3	–	Sell	-686,136	Closed	-$62.4M	–	149
2025 Q2	$62.4M	Buy	+686,136	New	+$62.6M	2.06%	15
2025 Q1	–	Sell	-689,065	Closed	-$62.6M	–	192
2024 Q4	$62.6M	Buy	+689,065	New	+$65.8M	4.01%	8
2024 Q3	–	Sell	-473,410	Closed	-$45.9M	–	26
2024 Q2	$45.9M	Buy	+473,410	New	+$43.7M	4.71%	11
2024 Q1	–	Sell	-1,488,356	Closed	-$119M	–	21
2023 Q4	$119M	Buy	+1,488,356	New	+$112M	16.57%	1

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ilex Capital Partners's CL Position: Q1 2026 in Review

Ilex Capital Partners sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 2,087,190 shares — an estimated $165M sold.

Ilex Capital Partners first reported a position in CL in Q4 2023 and held it in 5 quarters. The position peaked at $165M in Q4 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Ilex Capital Partners reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Ilex Capital Partners sold 2,087,190 Colgate-Palmolive shares in Q1 2026, an estimated $165M.
Ilex Capital Partners first reported a position in Colgate-Palmolive in Q4 2023 and held it in 5 quarters.
Ilex Capital Partners's Colgate-Palmolive position peaked at $165M in Q4 2025.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Ilex Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.